µGL
DEAD

Serial Number

77874351

Owner

SHIMADZU CORPORATION

Attorney

Tomoko Nakajima

Filing Date

Nov 17, 2009

Add to watchlist:

No watchlists yet
View on USPTO

µGL Trademark

Serial Number: 77874351 • Registration: 4072378

µGL is a trademark filed by SHIMADZU CORPORATION on November 17, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). The application is currently no longer active.

Owner Contact Info

SHIMADZU CORPORATION (285 trademarks)

1, NISHINOKYO KUWABARA-CHO
Nakagyo-ku, Kyoto 604-8511 , JP

Entity Type: 03

Trademark Details

Filing Date

November 17, 2009

Registration Date

December 20, 2011

Published for Opposition

October 4, 2011

Cancellation Date

July 27, 2018

Goods & Services

Laboratory apparatus and instruments, namely, genome and gene testers, detectors, and analyzers; Computer software for operating genetic testing, detecting, and analyzing laboratory equipment; Computer software for scientific analysis of genetic sequences; Measuring and testing instruments, namely, genetic polymorphism analyzers, detectors, and testing device; Electrical equipment for the genetic modification of cells for research purposes

Medical diagnostic reagents; Medical diagnostic reagents comprising DNA chips for clinical diagnosis; Reagents for medical use; Reagents and media for medical and veterinary diagnostic purposes; Reagents for clinical genetic diagnosis; Reagents for clinical biochemical diagnosis; Chemical reagents for medical purposes; Chemical reagents for clinical genetic diagnostics; Chemical reagents for clinical biochemical diagnostics; Chemical reagents in kit form for medical purposes; Chemical reagents in kit form for clinical genetic diagnostics; Chemical reagents in kit form for clinical biochemical diagnostics; Diagnostic reagents and contrast media for medical use; Diagnostic reagents for medicinal use; Test kits comprised of diagnostic reagents for clinical and medical use; Diagnostic preparations in kit form for medical purposes; Pharmaceutical preparations for use in genetic diseases; Test reagents for blood analysis for medical purpose

Reagent for chemical analyses; Reagents for research purposes; Reagents for scientific or medical research use; Assays and reagents for use in genetic research; Diagnostic reagents for clinical or medical laboratory use; Diagnostic reagents for in vitro use in biochemistry, clinical chemistry and microbiology; Diagnostic reagents and preparations, except for medical or veterinary use; Genetic identity tests comprised of reagents; and Reagent kits comprising DNA chips for use in biotechnology fields; Reagents for detecting bacteria food poisoning

Medical apparatus and instruments for medical diagnosis and genetic diagnostics; Medical apparatus and instruments for immunodiagnostics; Medical apparatus and instruments for biochemical diagnostics; Analyzers for medical purposes, namely, apparatus used to carry out automatic testing of biological samples; Medical apparatus and instruments for facilitating the analysis of biological and chemical matter in the field of genetic testing, namely blood, brain, urine, cerebrospinal fluid (csf) analysis and testing apparatus; Medical diagnosis devices, namely, analyzers and detectors of amplified viruses, extracted from human bodies; Apparatus for clinical diagnosis; Medical containers for medical reagent kits; Medical diagnostic devices, namely, kits consisting of containers, tubes, and genetic probes for extracting nucleic acid from biological samples; Medical diagnostic test kits consisting of testing containers and reagents for the purpose of detection and monitoring of inherited disease, genetic predispositions for medical conditions, drug responses, tumors or DNA conditions; Medical diagnostic apparatus and instruments, namely, devices with temperature controller and fluorescence detector for testing, analyzing, and evaluating biological material and samples for purpose of detection and monitoring of inherited disease, genetic predispositions for medical conditions, drug responses, tumors, and DNA conditions; Diagnostic apparatus for medical applications, namely, PCR machines, fluorescent detectors; Apparatus for diagnosing human genetic disease, infection disease, cardiac disease, tumors, and diabetes by the application of biochemical reaction

Filing History

CANCELLED SEC. 8 (6-YR)
Jul 27, 2018 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 20, 2016 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 20, 2011 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2011 NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 4, 2011 NPUB
PUBLISHED FOR OPPOSITION
Oct 4, 2011 PUBO
LAW OFFICE PUBLICATION REVIEW COMPLETED
Aug 27, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 24, 2011 CNSA
EXAMINER'S AMENDMENT ENTERED
Aug 24, 2011 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Aug 24, 2011 GNEN
EXAMINERS AMENDMENT E-MAILED
Aug 24, 2011 GNEA
EXAMINERS AMENDMENT -WRITTEN
Aug 24, 2011 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 23, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 23, 2011 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Aug 23, 2011 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Mar 10, 2011 GNS2
INQUIRY TO SUSPENSION E-MAILED
Mar 10, 2011 GNSI
SUSPENSION INQUIRY WRITTEN
Mar 10, 2011 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Feb 16, 2011 RCCK
ASSIGNED TO LIE
Feb 16, 2011 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Aug 13, 2010 GNS3
LETTER OF SUSPENSION E-MAILED
Aug 13, 2010 GNSL
SUSPENSION LETTER WRITTEN
Aug 13, 2010 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 16, 2010 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 16, 2010 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 30, 2010 TCCA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 23, 2010 GNRN
NON-FINAL ACTION E-MAILED
Feb 23, 2010 GNRT
NON-FINAL ACTION WRITTEN
Feb 23, 2010 CNRT
ASSIGNED TO EXAMINER
Feb 23, 2010 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 23, 2009 NWOS
NEW APPLICATION ENTERED
Nov 20, 2009 NWAP